- •
Traditional asthma controller medications are often unsuccessful in controlling the symptoms of patients with severe asthma.
- •
Bronchial thermoplasty presents a novel therapy in which radiofrequency energy is used to decrease bronchoconstriction by a reduction in airway smooth muscle.
- •
Current clinical evidence suggests that bronchial thermoplasty may be effective in reducing asthma exacerbations and improving asthma symptoms.
- •
Long-term data suggest that bronchial thermoplasty is safe and a disease
Bronchial Thermoplasty: A Novel Therapy for Severe Asthma
Section snippets
Key points
Airway smooth muscle in asthma
The smooth muscle within the walls of airways, or airway smooth muscle (ASM), has been postulated to play a role in multiple normal processes in the healthy airway, including regulation of bronchomotor tone, immunomodulation, and extracellular matrix deposition, although some also claim that it is a vestigial structure without a real salutary function.9 However, ASM mass is considerably increased in asthma when compared with healthy controls and these same processes contribute to the chronic
The Alair bronchial thermoplasty system
The Alair Bronchial Thermoplasty System comprises the Alair Controller System (Fig. 1), which includes the RF controller, a footswitch, and a return electrode, and the Alair catheter (Fig. 2), which contains an expandable 4-arm array and a handle with depressible actuator. The flexible catheter is 1.5 mm in diameter, sterile, disposable, and designed to be introduced in the working channel of a bronchoscope (ideally 4.9–5.2 mm outer diameter) with a working channel of at least 2.0 mm. Larger
Preprocedure assessment
The Food and Drug Administration has approved the Alair Bronchial Thermoplasty System for the treatment of severe persistent asthma in patients 18 years and older (Alair package insert). Selection criteria are outlined in Box 1 and are adapted from inclusion and exclusion criteria from the Asthma Intervention Research 2 (AIR2) trial, discussed later.19 A thorough clinical assessment of the patient is imperative before performing BT. To perform BT safely, any potential patient must have stable
Performing bronchial thermoplasty
BT should be performed by an experienced bronchoscopist in conjunction with an asthma specialist. Airways are treated in 3 separate sessions, each 3 weeks apart: the right lower lobe is treated in the first session, the left lower lobe in the second session, and both upper lobes in the final session. The right middle lobe is not treated because of concerns of airway collapse secondary to right middle lobe syndrome.20 In each session, the airway tree is carefully visualized, and the
Postprocedure assessment
After the BT procedure is complete, the patient should be monitored as per normal institutional postbronchoscopy guidelines. Patients may take longer to recover because of the greater amount of sedation typically required for BT, again due to the fact that BT often takes longer than typical bronchoscopy. Lung sounds should be auscultated immediately after the procedure and again before discharge. After patients recover from sedation, post-BT spirometry measurements are performed. Patients must
Clinical evidence for bronchial thermoplasty
The first trial of BT in humans was performed to determine the safety of the procedure in 8 subjects who were scheduled to undergo lung resection for suspected or proven lung cancer.21 All subjects tolerated the therapy well and proceeded to their planned surgery. One subject showed signs of airway narrowing but was asymptomatic. When the Alair system was used to apply a temperature of 65°C to the airways, a notable reduction in ASM was observed on histopathologic specimens. Subsequently, Cox
Summary
Bronchial thermoplasty is a novel treatment option for patients 18 years of age and older with severe asthma for whom management with conventional pharmacotherapy has been ineffective in controlling asthma symptoms. The procedure should be performed by an experienced bronchoscopist in conjunction with an asthma specialist. Clinical studies have shown improved asthma symptoms, fewer severe exacerbations, and decreased health care use with bronchial thermoplasty. Clinical experience has shown
References (31)
- et al.
Trends in asthma prevalence, health care use, and mortality in the United States, 2001-2010
NCHS Data Brief
(2012) - et al.
Costs of Asthma in the United States: 2002-2007
J Allergy Clin Immunol
(2011) - Akinbami LJ, Moorman JE, Liu X. Asthma prevalence, health care use, and mortality: United States, 2005-2009. National...
- et al.
A 15-year follow-up study of ventilatory function in adults with asthma
N Engl J Med
(1998) - et al.
Severe exacerbations and decline in lung function in asthma
Am J Respir Crit Care Med
(2009) - et al.
Severe exacerbations predict lung function decline in asthma
Eur Respir J
(2007) - et al.
Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute’s Severe Asthma Research Program
J Allergy Clin Immunol
(2007) Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions
Am J Respir Crit Care Med
(2000)- et al.
Airway smooth muscle in bronchial tone, inflammation, and remodeling
Am J Respir Crit Care Med
(2008) - et al.
Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma: a 3-D morphometric study
Am Rev Respir Dis
(1993)
Airway smooth muscle hypertrophy and hyperplasia in asthma
Am J Respir Crit Care Med
Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates
J Thorac Cardiovasc Surg
Management of hepatocellular carcinoma
Hepatology
Surgical ablation of atrial fibrillation with a novel bipolar radiofrequency device
J Thorac Cardiovasc Surg
Reduction of airway hyperresponsiveness to methacholine by the application of RF energy in dogs
J Appl Physiol
Cited by (14)
Imaging procedures and bronchial thermoplasty for asthma assessment and intervention
2018, Personalizing Asthma Management for the ClinicianImaging Procedures and Bronchial Thermoplasty for Asthma Assessment and Intervention
2017, Personalizing Asthma Management for the ClinicianIL-27 alleviates airway remodeling in a mouse model of asthma via PI3K/Akt pathway
2020, Experimental Lung ResearchAnesthetic considerations for patients undergoing bronchial thermoplasty
2018, Anesthesia and Analgesia
Disclosures: A. Sheshadri has no professional or financial interests to disclose. A. Chen has lectured for Asthmatx/Boston Scientific. M. Castro served as consultant or on the advisory board for Genentech, IPS, Medimmune, NKT Therapeutics, and Schering. He lectured for Asthmax/Boston Scientific, Boehringer Ingelheim, Genentech, GSK, Merck, and Pfizer. His University received industry-sponsored grants from Amgen, Asthmatx/Boston Scientific, Ception/Cephalon, Genentech, GSK, Kalbios, MedImmune, Merck, Novartis, and Sanofi-Aventis. His University received grant monies from the NIH and the ALA and received royalties from Elsevier.